The numbers didn’t lie, but my trust did. I remember the exact moment in late 2017 when I audited a synthetic asset protocol that promised to mirror real-world equities. The code was clean, the math tight. But the settlement oracle was a single point of failure—a price feed from a single exchange. I missed it. $1.2 million in ETH drained. That failure taught me one thing: the gap between a product’s promise and its execution is where the real risks hide. Now, I see that same gap in the Hyperliquid Policy Center (HPC) and trade[XYZ]’s recent letter to the SEC, proposing Initial Pre-IPO Perpetuals (IPOPs). They claim to offer a new price discovery mechanism for upcoming IPOs. But the data they present—5 markets, discounts of 10.8% to 38.4%—is a mirror. I’ve learned to look for the reflection of trust, not the image of numbers.
Context: The IPOP Proposal
In the letter dated August 19 (year unspecified), HPC and trade[XYZ] urged the SEC to consider IPOPs as a tool for transparent, continuous price discovery before an IPO. An IPOP is a synthetic perpetual contract that tracks the price of a company that has filed for an IPO. It allows long and short positions, but confers no equity, allocation rights, or voting power. The contract terminates automatically upon the IPO listing, with settlement presumably based on the opening price. The proponents argue that IPOPs address the well-known IPO underpricing problem—where issuers intentionally set the offer price below market value—by letting the market express its valuation ahead of time. They cite data from five completed IPOP markets on Hyperliquid: the final IPOP prices before listing were 10.8% to 38.4% higher than the IPO issue price, yet the first trade price on the exchange matched the IPOP price within 0.5% to 1.3%. To them, this is proof of accuracy. To me, it’s a sample size of five, with no independent audit.
Core: Order Flow Analysis and the Game-Theoretic Trap
Let me dig into the design. An IPOP is not a new blockchain—it’s a derivative product on Hyperliquid’s order book. The innovation is in the lifecycle: the contract is created when a company files for IPO, trades until listing, and then settles. The underlying technology is the same perpetual swap mechanism that Hyperliquid uses for crypto pairs. That’s fine. But the critical unknown is the settlement price source. Is it the IPO price, the first trade on the exchange, or a volume-weighted average of the first hour? The letter doesn’t say. In my experience, if the settlement is tied to a single event (e.g., the first trade on the NYSE), then the market can be front-run by anyone with access to the order flow. I built an arbitrage bot for Curve in 2020 that exploited exactly this kind of information asymmetry. The lesson: when the settlement is a black box, the smart money doesn’t trade—it manipulates.
Now, consider the incentives. trade[XYZ] is likely a market maker on Hyperliquid. They earn fees and possibly rebates from the IPOP markets. Their letter to the SEC is not a public service announcement; it’s a business development pitch. They want regulatory clarity to expand their product and attract traditional finance liquidity. The data they present—the 10.8% to 38.4% discount—is a selling point. But it also reveals a potential flaw: if IPOP prices are consistently above the IPO price, then the market is inefficient. A rational trader would short the IPOP and buy the IPO allocation, if they could get it. But retail traders can’t. So the IPOP market is a playground for institutions and insiders. I built a liquidity pool once, but lost my liquidity. The same principle applies here: if the only liquidity providers are the same entities that control the settlement, the pool is a trap.
Let me apply my game-theoretic lens. The five IPOP markets were likely small, with low liquidity. The reported accuracy (0.5% to 1.3% deviation) is impressive but suspicious. In a low-liquidity environment, a single large order can set the price. The market maker could have easily smoothed the price to match the eventual listing. This is not price discovery; it’s price alignment. The real test will come when the market has high volume and multiple competing interests. That’s when the cracks appear. In my copy trading community, I’ve seen this pattern repeatedly: a new product launches with perfect data, then real money arrives and the strategy fails. The numbers didn’t lie, but the context did.
Contrarian: Retail vs. Smart Money
The retail narrative is simple: “Pre-IPO trading! I can get in early on the next big stock before it lists.” The smart money narrative is different: “This is a synthetic derivative with no equity, no rights, and no clear regulatory status. The settlement is opaque. The only verified data comes from the proposer. The SEC hasn’t responded. This is a high-risk lottery ticket.” The contrast is stark. The retail trader sees a new market; the smart money sees a regulatory gamble and a potential manipulation arena. In traditional pre-IPO markets, only accredited investors can buy shares through platforms like Forge or EquityZen. Those are actual equity transfers with legal protections. IPOPs are synthetic contracts—you don’t own the stock. If the contract is mispriced or the settlement is disputed, your recourse is the Hyperliquid network, not the SEC. That’s a thin line.
Think about the information asymmetry. The people who know the most about a company’s IPO—the underwriters, the company insiders, the exchange officials—are not allowed to trade. But the IPOP market is open to anyone with a Hyperliquid account. The risk of insider trading is enormous. The SEC will see that. They may not care about the “decentralization” of the settlement; they care about market integrity. The fact that HPC and trade[XYZ] proactively raised the issues of “regulatory classification, disclosure, listing eligibility, market integrity, and investor accessibility” in their letter suggests they are aware of these risks. But proactive awareness does not equal mitigation. Flows change, but the current remains. The current of regulatory scrutiny is strong, and it will pull the IPOP product into its path.
Takeaway: Actionable Price Levels and Forward-Looking Judgment
So, what does this mean for a trader? First, the immediate impact on Hyperliquid’s token (HYPE) is likely muted. The letter is a procedural event, not a catalyst. The real action will come if the SEC responds positively or negatively. A positive response would open the door for IPOPs as a regulated product, potentially attracting institutional liquidity. A negative response could force the product to shut down for US users, reducing trading volume. The data from the five completed IPOPs is not actionable—it’s a retrospective sample. The forward-looking judgment is this: Silence is the loudest audit. If the SEC stays silent, the product will continue in a gray zone. If they speak, the market will move. Watch for any SEC filing, comment letter, or enforcement action. That’s the trigger.
For the tactical trader: if you must trade IPOPs, size small. The liquidity is thin, and the settlement risk is unknown. Treat it as a high-beta event contract, not a perpetual. The discount to IPO price is a statistical artifact—it will not persist in a liquid market. The smart money will short the spread, and the retail will get caught. I’ve seen this play out in DeFi yield farming, in NFT minting, and now in pre-IPO derivatives. Art burns hot; patience burns colder. Wait for the regulatory clarity. The market will still be there. The numbers may not lie, but the trust in those numbers needs to be verified. Silence is the loudest audit. I’ll wait for the SEC to speak.
Final note: This is not financial advice. It’s the reflection of a battle-tested trader who has lost trust in numbers and learned to trust the incentives behind them. The IPOP proposal is a mirror. Look at it carefully, and you’ll see the reflection of the market’s true nature—a game of trust, not just price.